BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
174 hedge funds and large institutions have $303M invested in bluebird bio in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
+2
Holders Change %
+1.16%
% of All Funds
2.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
54
Reduced
45
Closed
32
Calls
$961K
Puts
$2.09M
Net Calls
-$1.13M
Net Calls Change
+$601K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$63.8M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
$7.52M |
| 3 |
Morgan Stanley
New York
|
$7.63M |
| 4 |
Renaissance Technologies
New York
|
$4.56M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
$4.18M |
